Emergency Department, Manchester University NHS Foundation Trust, Manchester, UK
Division of Cardiovascular Sciences, The University of Manchester, Manchester, UK.
Emerg Med J. 2022 Jan;39(1):70-76. doi: 10.1136/emermed-2021-211814. Epub 2021 Nov 5.
Point-of-care tests for SARS-CoV-2 could enable rapid rule-in and/or rule-out of COVID-19, allowing rapid and accurate patient cohorting and potentially reducing the risk of nosocomial transmission. As COVID-19 begins to circulate with other more common respiratory viruses, there is a need for rapid diagnostics to help clinicians test for multiple potential causative organisms simultaneously.However, the different technologies available have strengths and weaknesses that must be understood to ensure that they are used to the benefit of the patient and healthcare system. Device performance is related to the deployed context, and the diagnostic characteristics may be affected by user experience.This practice review is written by members of the UK's COVID-19 National Diagnostic Research and Evaluation programme. We discuss relative merits and test characteristics of various commercially available technologies. We do not advocate for any given test, and our coverage of commercially supplied tests is not intended to be exhaustive.
即时检测 SARS-CoV-2 可实现 COVID-19 的快速确诊和/或排除，从而实现快速、准确的患者分类，并有可能降低医院内传播的风险。随着 COVID-19 开始与其他更常见的呼吸道病毒一起传播，需要快速诊断方法来帮助临床医生同时检测多种潜在的病原体。然而，不同的现有技术具有各自的优势和劣势，为了确保将其用于患者和医疗体系的获益，必须对这些技术有充分的了解。设备性能与部署环境相关，诊断特征可能会受到用户体验的影响。本实践综述由英国 COVID-19 国家诊断研究和评估计划的成员撰写。我们讨论了各种市售技术的相对优势和测试特点。我们并不提倡使用任何特定的检测方法，而且我们对市售检测方法的介绍也不是详尽无遗的。
